In This Article:
MicroPort Scientific and Yangtze Optical Fibre And Cable Limited can add profound upside to your portfolio. This is because the optimistic growth outlook for their profitability and returns make their high-growth potential appealing relative to their peers. Below I’ve put together a list of great potential investments for you to consider adding to your portfolio if growth is a dimension you would like to firm up.
MicroPort Scientific Corporation (SEHK:853)
MicroPort Scientific Corporation, an investment holding company, manufactures and markets medical devices in the People’s Republic of China, North America, Europe, other Asian countries, South America, and internationally. Established in 1998, and now run by Zhaohua Chang, the company provides employment to 3,108 people and with the company’s market cap sitting at HKD HK$14.23B, it falls under the large-cap category.
853’s projected future profit growth is a robust 38.85%, with an underlying 36.71% growth from its revenues expected over the upcoming years. Profit growth, coupled with top-line expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. We see this bottom-line expansion directly benefiting shareholders, with expected positive return on equity of 13.58%. 853’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Considering 853 as a potential investment? Other fundamental factors you should also consider can be found here.
Yangtze Optical Fibre And Cable Joint Stock Limited Company (SEHK:6869)
Yangtze Optical Fibre and Cable Joint Stock Limited Company manufactures and sells optical fiber and cable products in the People’s Republic of China and internationally. Formed in 1988, and currently headed by CEO Dan Zhuang, the company employs 4,075 people and with the stock’s market cap sitting at HKD HK$22.24B, it comes under the large-cap category.
6869 is expected to deliver an extremely high earnings growth over the next couple of years of 16.36%, driven by a positive double-digit revenue growth of 32.07% and cost-cutting initiatives. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 21.52%. 6869’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Considering 6869 as a potential investment? Other fundamental factors you should also consider can be found here.